September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Validating impact of temporal changes of adiponectin in relation to ROP development
Author Affiliations & Notes
  • Chatarina Lofqvist
    Institute of Neuroscience and Physiology, Department of Ophthalmology, University of Gothenburg, Gothenburg, Sweden
  • Gunnel Hellgren
    Institute of Neuroscience and Physiology, Department of Ophthalmology, University of Gothenburg, Gothenburg, Sweden
    Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden
  • Svetlana Najm
    Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden
  • Eva Engström
    Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden
  • Lennart Stigson
    Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden
  • Lois E H Smith
    Department of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, United States
  • Anna-Lena Hård
    Institute of Neuroscience and Physiology, Department of Ophthalmology, University of Gothenburg, Gothenburg, Sweden
  • Karin Sävman
    Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden
  • Ann Hellstrom
    Institute of Neuroscience and Physiology, Department of Ophthalmology, University of Gothenburg, Gothenburg, Sweden
  • Footnotes
    Commercial Relationships   Chatarina Lofqvist, None; Gunnel Hellgren, None; Svetlana Najm, None; Eva Engström, None; Lennart Stigson, None; Lois Smith, None; Anna-Lena Hård, None; Karin Sävman, None; Ann Hellstrom, None
  • Footnotes
    Support  This study has been supported by the Swedish Medical Research Council (# 2011-2432), the European Commission FP7 project 305485 PREVENT-ROP, Swedish government grants (#ALFGB2770)
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6297. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Chatarina Lofqvist, Gunnel Hellgren, Svetlana Najm, Eva Engström, Lennart Stigson, Lois E H Smith, Anna-Lena Hård, Karin Sävman, Ann Hellstrom; Validating impact of temporal changes of adiponectin in relation to ROP development. Invest. Ophthalmol. Vis. Sci. 2016;57(12):6297.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To validate earlier found physiologic response patterns explaining retinopathy of prematurity (ROP) development in infants born very preterm. Generally adiponectin production is up-regulated by weight loss and down regulated by weight gain, oxidative stress as well as pro-inflammatory cytokines. Disturbed homeostasis, impaired growth and inflammation are factors closely related to ROP development. This study assessed the longitudinal postnatal development of serum adiponectin levels and ROP development in a new cohort of very preterm infants.

Methods : A study was performed in 90 infants with gestational age (GA) < 28 weeks with a mean (SD) gestational age at birth of 25.2 (1.4) weeks and mean (SD) birth weight of 882 (220) g. Cord blood samples and thereafter venous blood samples were obtained at postnatal day 1, 7, 14, 28 days and at postmenstrual age 32, 36 and 40 weeks. Serum adiponectin levels were assayed using a human adiponectin ELISA kit (E091M, Mediagnost, Germany). The intra-assay CVs were 3.8% at 3.9 µg/mL and 4.7% at 13.1 µg/mL and the inter-assay CV was 16.3% at 9.9 µg/mL. ROP was determined according to the International ROP classification.

Results : Thirteen infants died before completing 40 weeks. ROP stages were assessed in 77 infants and grouped as ROP stage 0 (n=16), ROP stage 1 (n=11), ROP stage 2 (n=20) and ROP stage 3 (n=30). The temporal pattern showed that mean adiponectin concentrations increased steeply during the first 14 days after birth from 2.7 ± 3.7 (mean ± SD) µg/mL at day 1 to 47.3 ± 25.6 µg/mL at 14 days (P < 0.001). From 28 days after birth to 32 weeks postmenstrual age mean adiponectin levels gradually decreased.Mean adiponectin levels were consistently significantly lower in infants who developed proliferative ROP compared to infants with no ROP from birth up to postmenstrual age 32 weeks. During postmenstrual weeks 36 to 40 weeks mean adiponectin gradually increased to levels comparable to levels seen at 14 days after birth. Interestingly no significant difference in mean adiponectin levels were seen between ROP stages at this period.

Conclusions : Serum adiponectin levels exhibit an interesting biphasic response pattern in very preterm infants with a rapid increase during the first weeks after birth followed by a decrease and then a new increase. Persistent lower adiponectin levels were found in infants developing ROP at a time point preceeding ROP development.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×